In multiple cancer cell models, NRF2 silencing has been shown to reduce HIF-1α levels, resulting in the suppression of HIF-1α-mediated cell proliferation, angiogenesis, tumor growth, and migration/invasion45,51–55. This evidence concerns the gene HIF1A and cancer.